What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0001762304
Total reported value
$832.1M
$832.1M
78 檔
352.1%
As reported in its official Q2 2024 Form 13F filing, Hhlr Advisors, LTD.'s tracked investment portfolio stood at $832.1M with 78 total positions.
During Q2 2024, Hhlr Advisors, LTD.'s portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
In terms of portfolio concentration, the top 5 core holdings (including PDD, ONC, BABA) accounted for 352.1% of total reported equity market value during Q2 2024.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | PDD | Pdd Holdings Inc | Stock-Consumer Disc | 29.16% | -20.86% | -24.59% | |
| 2 | ONC | Beone Medicines Ltd-adr | Stock-Other | 18.22% | -18.36% | EXIT | |
| 3 | BABA | Alibaba Group Holding-sp Adr | Stock-Consumer Disc | 9.55% | -16.28% | +3638.32% | |
| 4 | BEKE | Ke Holdings Inc-adr | Stock-Other | 8.09% | +0.08% | -20.59% | |
| 5 | LEGN | Legend Biotech Corp-adr | Stock-Other | 7.25% | +14.30% | +10.89% | |
| 6 | VIPS | Vipshop Holdings LTD - Adr | Stock-Consumer Disc | 4.76% | +5.41% | +7355.19% | |
| 7 | NTES | Netease Inc-adr | Stock-Comm Services | 3.27% | +0.54% | NEW | |
| 8 | AVBP | Arrivent Biopharma Inc | Stock-Other | 2.05% | +10.98% | +14.14% | |
| 9 | TCOM | Trip.com Group Ltd-adr | Stock-Consumer Disc | 1.61% | — | — | |
| 10 | KNSA | Kiniksa Pharmaceuticals International, plc | Stock-Other | 1.45% | — | — | |
| 11 | FUTU | Futu Holdings Ltd-adr | Stock-Financials | 1.16% | +8.32% | — | |
| 12 | ✓ | Enfusion Inc - Class A | Stock-Other | 1.05% | — | — | |
| 13 | CTKB | Cytek Biosciences Inc | Stock-Other | 0.92% | +1.80% | — | |
| 14 | BBIO | Bridgebio Pharma Inc | Stock-Healthcare | 0.87% | — | +1.69% | |
| 15 | DHR | Danaher CORP | Stock-Healthcare | 0.67% | — | -76.93% | |
| 16 | DASH | Doordash Inc - A | Stock-Consumer Disc | 0.67% | — | -57.51% | |
| 17 | CRM | Salesforce Inc | Stock-Tech | 0.61% | — | -79.15% | |
| 18 | META | Meta Platforms Inc-class A | Stock-Comm Services | 0.55% | — | +641.27% | |
| 19 | AZNN | Astrazeneca Plc-spons Adr | Stock-Other | 0.52% | — | — | |
| 20 | HTHT | H World Group Ltd-adr | Stock-Other | 0.47% | — | -39.25% | |
| 21 | YSG | Yatsen Holding Ltd-adr | Stock-Other | 0.46% | +0.96% | — | |
| 22 | APP | Applovin Corp-class A | Stock-Tech | 0.45% | — | +66.97% | |
| 23 | ✓ | On Holding AG | Stock-Other | 0.39% | — | — | |
| 24 | GOOG | Alphabet Inc-cl C | Stock-Comm Services | 0.32% | — | +18.38% | |
| 25 | GERN | Geron CORP | Stock-Other | 0.31% | — | — | |
| 26 | SE | Sea Ltd-adr | Stock-Comm Services | 0.31% | — | — | |
| 27 | CTNM | Contineum Therapeutics Inc-a | Stock-Other | 0.29% | +0.80% | — | |
| 28 | TSM | Taiwan Semiconductor-sp Adr | Stock-Tech | 0.29% | +0.58% | -31.91% | |
| 29 | NBP | Novabridge Biosciences | Stock-Other | 0.28% | +0.52% | — | |
| 30 | TMO | Thermo Fisher Scientific Inc | Stock-Healthcare | 0.25% | — | — | |
| 31 | STVN | Stevanato Group S.p.A. | Stock-Other | 0.25% | — | — | |
| 32 | SOHU | Sohu.com Ltd-adr | Stock-Other | 0.24% | — | — | |
| 33 | NVDA | Nvidia CORP | Stock-Tech | 0.24% | +0.27% | +471.32% | |
| 34 | MU | Micron Technology Inc | Stock-Tech | 0.23% | — | +0.42% | |
| 35 | MSFT | Microsoft CORP | Stock-Tech | 0.23% | — | -96.99% | |
| 36 | CPNG | Coupang Inc | Stock-Consumer Disc | 0.23% | — | -59.26% | |
| 37 | AAPL | Apple Inc | Stock-Tech | 0.21% | — | +246.15% | |
| 38 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 0.20% | — | -94.93% | |
| 39 | ASML | ASML Holding N.V. | Stock-Tech | 0.13% | — | +59.73% | |
| 40 | GOSS | Gossamer Bio Inc | Stock-Other | 0.11% | — | — | |
| 41 | RBLX | Roblox CORP -class A | Stock-Comm Services | 0.10% | — | — | |
| 42 | S | Sentinelone Inc -class A | Stock-Tech | 0.09% | — | — | |
| 43 | URA | Global X Uranium ETF | ETF-Other | 0.09% | — | +20.00% | |
| 44 | ANETEUR | Arista Networks Inc | Stock-Other | 0.08% | — | +172.22% | |
| 45 | EM | Smart Share Global LTD - Adr | Stock-Other | 0.08% | — | — | |
| 46 | MGX | Metagenomi Therapeutics Inc | Stock-Other | 0.08% | — | — | |
| 47 | QCOM | Qualcomm Inc | Stock-Tech | 0.07% | — | +403.33% | |
| 48 | ZKN | Zeekr Intelligent Techno-adr | Stock-Other | 0.07% | — | — | |
| 49 | TUYA | Tuya Inc | Stock-Other | 0.07% | +0.11% | — | |
| 50 | BCYC | Bicycle Therapeutics Plc-adr | Stock-Other | 0.06% | — | — |
According to official SEC Form 13F filings, Hhlr Advisors, LTD. reported a total U.S. public equity portfolio value of $832.1M across 78 disclosed positions in Q2 2024.
During Q2 2024, Hhlr Advisors, LTD.'s top holdings by market value included PDD (29.2%)、ONC (18.2%)、BABA (9.6%). The largest single position, PDD, represented 29.2% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In Q2 2024, Hhlr Advisors, LTD. made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.